Over-expressing homologous antigen vaccine and a method of making the same
The Regents of the University of California
Virginia Tech Intellectual Properties, Inc.
Boyle, Stephen M.
Corbeil, Lynette B.
Schurig, Gerhardt G.
MetadataShow full item record
This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering from disease caused by a pathogenic micro-organism. The vaccine is an attenuated or avirulent pathogenic micro-organism that over-expresses at least one homologous antigen encoded by at least one gene derived from the pathogenic micro-organism, and may also express a heterologous antigen.
- Virginia Tech Patents